Paradoxical strategy for treating chronic diseases where the therapeutic effect is derived from compensatory response rather than drug effect

Medical Hypotheses

Volumn 64, Issue 5, 2005, Pages 1050-1059

  Yun, Anthony J ^a   Lee, Patrick Y ^a   Bazar, Kimberly A ^b  

^a STANFORD UNIVERSITY   (United States)

^b San Mateo County Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BROMOCRIPTINE; CHLORPROMAZINE; DRUG CARRIER; ERYTHROPOIETIN; ESTROGEN; GLUCOCORTICOID; GROWTH HORMONE RELEASING FACTOR; HALOPERIDOL; INSULIN; LEVODOPA; METOPROLOL; NITRATE; OPIATE; PREDNISONE; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; TANDOSPIRONE; TIMOLOL;

AGING; ANXIETY; ARTICLE; ASTHMA; AUTONOMIC DYSFUNCTION; AUTONOMIC NERVE; BONE DEMINERALIZATION; CANCER; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CLINICAL TRIAL; DEPRESSION; DIABETES MELLITUS; DIZZINESS; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG RESPONSE; DRUG TOLERANCE; EXERCISE; GASTROINTESTINAL SYMPTOM; HEART RATE VARIABILITY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; IMMUNOPATHOLOGY; IMPOTENCE; INSOMNIA; INSULIN TREATMENT; INTRAOCULAR HYPERTENSION; MACHADO JOSEPH DISEASE; PAIN; PARASYMPATHETIC NERVE; PARKINSON DISEASE; PRIORITY JOURNAL; PULSATILE DRUG RELEASE; RESPIRATORY TRACT INFLAMMATION; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; SPASTICITY; SYMPATHETIC NERVE; SYMPATHETIC TONE; VAGUS TONE;

EID: 15244342776     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.09.007     Document Type: Article

References (106)

1. P. Tandon, F.A. McAlister, and R.T. Tsuyuki The use of β-blockers in a tertiary care heart failure clinic: dosing, tolerance, and outcomes Arch Intern Med 164 7 2004 769 774
2. L. Brynne, L.K. Paalzow, and M.O. Karlsson Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats J Pharmacol Exp Ther 290 2 1999 664 671
3. A.J. Yun, P.Y. Lee, and K.A. Bazar Many diseases may reflect dysfunctions of autonomic balance attributable to evolutionary displacement Med Hypotheses 62 6 2004 847 851
4. Yun AJ, Lee PY, Bazar KA. A new mechanism for diverticular diseases: aging-related vagal withdrawal. Med Hypotheses 2004, doi:10.1016/j.mehy.2004.07. 010
5. M. Golder, D.E. Burleigh, and A. Belai Smooth muscle cholinergic denervation hypersensitivity in diverticular disease Lancet 361 9373 2003 42 46
6. N.L. Benowitz, S. Zevin, S. Carlsen, J. Wright, M. Schambelan, and M. Cheitlin Orthostatic hypertension due to vascular adrenergic hypersensitivity Hypertension 28 1 1996 42 46
7. K. Araki, Y. Ueda, I. Kono, T. Ookawara, and K. Kashima A case of neurogenic orthostatic hypertension Jpn J Med 30 5 1991 446 451
8. N.M. Kaplan Two faces of sympathetic nervous activity: hypotension and hypertension Am J Med Sci 303 4 1992 271 279
9. R.J. Polinsky, I.J. Kopin, M.H. Ebert, and V. Weise Pharmacologic distinction of different orthostatic hypotension syndromes Neurology 31 1 1981 1 7
10. D.S. Goldstein Arterial baroreflex sensitivity, plasma catecholamines, and pressor responsiveness in essential hypertension Circulation 68 2 1983 234 240
11. J.C. Luck, R.J. Hoover, R.W. Biederman, S.M. Ettinger, L.I. Sinoway, and U.A. Leuenberger Observations on carotid sinus hypersensitivity from direct intraneural recordings of sympathetic nerve traffic Am J Cardiol 77 15 1996 1362 1365
12. R.A. Kenny, and G. Traynor Carotid sinus syndrome-clinical characteristics in elderly patients Age Ageing 20 6 1991 449 454
13. R.D. Bunag, T. Tomita, and D. Krizsan Renovascular β-adrenergic hypersensitivity and hyperinsulinemia in rats with dietary-induced obesity J Pharmacol Exp Ther 255 1 1990 325 332
14. S. Yusuf, R. Peto, J. Lewis, R. Collins, and P. Sleight β-Blockade during and after myocardial infarction: an overview of the randomized trials Prog Cardiovasc Dis 27 5 1985 335 371
15. M.S. Guirguis, and F. Jamali Disease-drug interaction: reduced response to propranolol despite increased concentration in the rat with inflammation J Pharm Sci 92 5 2003 1077 1084
16. M. Burnier Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertension Blood Press Monit 5 Suppl. 1 2000 S31 S34
17. M. Batterbury, S.P. Harding, and D. Wong Long-term drift and timolol therapy: possible role for pulsed therapy Int Ophthalmol 16 4-5 1992 321 324
18. S.A. Gandolfi Restoring sensitivity to timolol after long-term drift in primary open-angle glaucoma Invest Ophthalmol Vis Sci 31 2 1990 354 358
19. A. De Blasi, P.L. Pittana, M. Fratelli, and S. Garattini Reduction of β-adrenergic receptors can explain the lack of rebound effect after tertatolol withdrawal Am J Hypertens 2 11 Pt 2 1989 257S 260S
20. M.J. Abramson, J. Walters, and E.H. Walters Adverse effects of β-agonists: are they clinically relevant? Am J Respir Med 2 4 2003 287 297
21. Y. Kassif, U. Rehany, and S. Rumelt Metoprolol responding uveitis Eye 18 1 2004 41 43
22. J.R. Gage, G. Fonarow, M. Hamilton, M. Widawski, O. Martinez-Maza, and D.L. Vredevoe β-Blocker and angiotensin-converting enzyme inhibitor therapy is associated with decreased Th1/Th2 cytokine ratios and inflammatory cytokine production in patients with chronic heart failure Neuroimmunomodulation 11 3 2004 173 180
23. M. Kollai, and K. Koizumi Reciprocal and non-reciprocal action of the vagal and sympathetic nerves innervating the heart J Auton Nerv Syst 1 1 1979 33 52
24. H. Tsuji, M.G. Larson, and F.J. Venditti Jr. Impact of reduced heart rate variability on risk for cardiac events: The Framingham Heart Study Circulation 94 11 1996 2850 2855
25. H. Tsuji, F.J. Venditti Jr., and E.S. Manders Reduced heart rate variability and mortality risk in an elderly cohort: The Framingham Heart Study Circulation 90 2 1994 878 883
26. A.I. Larsen, K. Gjesdal, C. Hall, P. Aukrust, T. Aarsland, and K. Dickstein Effect of exercise training in patients with heart failure: a pilot study on autonomic balance assessed by heart rate variability Eur J Cardiovasc Prev Rehabil 11 2 2004 162 167
27. D.M. Pober, B. Braun, and P.S. Freedson Effects of a single bout of exercise on resting heart rate variability Med Sci Sports Exerc 36 7 2004 1140 1148
28. R. Jurca, T.S. Church, G.M. Morss, A.N. Jordan, and C.P. Earnest Eight weeks of moderate-intensity exercise training increases heart rate variability in sedentary postmenopausal women Am Heart J 147 5 2004 e21
29. M.D. Eisner, M. Abramson, and M. Bailey Inhaled β-agonists and death from asthma: revisiting the controversy Am J Respir Crit Care Med 163 6 2001 1502
30. A.J. Yun, P.Y. Lee, and K.A. Bazar Acute coronary syndrome and heart failure may reflect maladaptations of trauma physiology that was shaped during pre-modern evolution Med Hypotheses 62 6 2004 861 867
31. J. Crane, N. Pearce, and A. Flatt Prescribed fenoterol and death from asthma in New Zealand 1981-1983: a case control study Lancet 1 8644 1989 917 922
32. M.J. Abramson, M.J. Bailey, and F.J. Couper Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med 163 1 2001 12 18
33. One on one. The β-blocker I take has slowed my heart rate, making it difficult to achieve my target heart rate when I exercise. Does this mean the exercise isn't doing me any good? Mayo Clin Womens Healthsource 2004;8(9):8
34. H.B. Simon I am a 46-year-old man with hypertension. I recently started taking Inderal for my blood pressure. I feel fine and my pressure is way down, but I can no longer get my pulse up when I work out on my treadmill or bike. Does that mean I won't benefit from exercise anymore? Harv Mens Health Watch 4 3 1999 8
35. M. Wonisch, P. Hofmann, and F.M. Fruhwald Influence of β-blocker use on percentage of target heart rate exercise prescription Eur J Cardiovasc Prev Rehabil 10 4 2003 296 301
36. V.K. Munagala, V. Guduguntla, B. Kasravi, G. Cummings, and J.M. Gardin Use of atropine in patients with chronotropic incompetence and poor exercise capacity during treadmill stress testing Am Heart J 145 6 2003 1046 1050
37. M. Blanchet, A. Ducharme, and N. Racine Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of β-adrenergic blockade (carvedilol or metoprolol) Am J Cardiol 92 5 2003 548 553
38. T. Glaab, and T. Weiss Use of β-blockers in cardiovascular diseases and bronchial asthma/COPD Internist (Berl) 45 2 2004 221 227
39. A. Silvestri, P. Galetta, and E. Cerquetani Report of erectile dysfunction after therapy with β-blockers is related to patient knowledge of side effects and is reversed by placebo Eur Heart J 24 21 2003 1928 1932
40. Y. Yamada, F. Shibuya, J. Hamada, Y. Sawada, and T. Iga Prediction of sleep disorders induced by β-adrenergic receptor blocking agents based on receptor occupancy J Pharmacokinet Biopharm 23 2 1995 131 145
41. D.S. Bell Advantages of a third-generation β-blocker in patients with diabetes mellitus Am J Cardiol 93 9A 2004 49B 52B
42. P.Y. Marie, P.M. Mertes, and N. Hassan-Sebbag Exercise release of cardiac natriuretic peptides is markedly enhanced when patients with coronary artery disease are treated medically by β-blockers J Am Coll Cardiol 43 3 2004 353 359
43. P.Y. Marie, C. Mercennier, and N. Danchin Residual exercise SPECT ischemia on treatment is a main determinant of outcome in patients with coronary artery disease treated medically at long-term with β-blockers J Nucl Cardiol 10 4 2003 361 368
44. R.D. Penn, and J.S. Kroin Long-term intrathecal baclofen infusion for treatment for spasticity J Neurosurg 66 2 1987 181 185
45. J.R. Coffey, D. Cahill, and W. Steers Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study J Neurosurg 78 2 1993 226 232
46. J.M. Meythaler, W.D. Steers, M. TuelS, L.L. Cross, and C.S. Haworth Continuous intrathecal baclofen in spinal cord spasticity: a prospective study Am J Phys Med Rehabil 71 2 1992 321 327
47. N.A. Abel, and R.A. Smith Intrathecal baclofen for treatment of intractable spinal spasticity Arch Phys Med Rehabil 75 1 1994 54 58
48. M. Wallace, and T.L. Yaksh Long-term spinal analgesic delivery: a review of the preclinical and clinical literature Reg Anesth Pain Med 25 2 2000 117 157
49. K. Hara, Y. Saito, Y. Kirihara, Y. Yamada, S. Sakura, and Y. Kosaka The interaction of antinociceptive effects of morphine and GABA receptor agonist within the rat spinal cord Anesth Analg 89 2 1999 422 427
50. J. Vidal, P. Gregori, D. Guevara, E. Portell, and M. Valles Efficacy of intrathecal morphine in the treatment of baclofen tolerance in a patient on intrathecal baclofen therapy (ITB) Spinal Cord 42 1 2004 50 51
51. M. Lorenz, S. Hussein, and L. Verner Continuous intraventricular clonidine infusion in controlled morphine withdrawal-case report Pain 98 3 2002 335 338
52. C. Breitfeld, M. Eikermann, P. Kienbaum, and J. Peters Opioid "holiday" following antagonist supported detoxification during general anesthesia improves opioid agonist response in a cancer patient with opioid addiction Anesthesiology 98 2 2003 571 573
53. K.L. Lenz, and D.S. Dunlap Continuous fentanyl infusion: use in severe cancer pain Ann Pharmacother 32 3 1998 316 319
54. S. Mercadante, P. Villari, P. Ferrera, and E. Arcuri Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain Anesth Analg 97 1 2003 187 189
55. T. Corona, C. Rivera, E. Otero, and L. Stopp A longitudinal study of the effects of an l-dopa drug holiday on the course of Parkinson's disease Clin Neuropharmacol 18 4 1995 325 332
56. O. Rascol Medical treatment of levodopa-induced dyskinesias Ann Neurol 47 4 Suppl 1 2000 S179 S188
57. J.G. Nutt, J.H. Carter, and W.R. Woodward Effect of brief levodopa holidays on the short-duration response to levodopa: evidence for tolerance to the antiparkinsonian effects Neurology 44 9 1994 1617 1622
58. A.M. Kenny, M.B. Schneider, D.R. Baden, R.F. Pfeiffer, and L.C. Murrin Bromocriptine holiday: effects on dopamine receptors and turning behavior in rats Neurology 36 3 1986 400 444
59. L.K. Direnfeld, R.G. Feldman, M.P. Alexander, and M. Kelly-Hayes Is l-DOPA drug holiday useful? Neurology 30 7 Pt 1 1980 785 788
60. A.J. Rothschild Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday Am J Psychiatry 152 10 1995 1514 1516
61. L.A. Hershey, T. Gift, R.W. Atkins, and L. Rivera-Calimlim Effect of a drug holiday on plasma chlorpromazine levels in chronic schizophrenic patients Psychopharmacology (Berl) 73 4 1981 355 358
62. J.E. Newton, D.J. Cannon, and L. Couch Effects of repeated drug holidays on serum haloperidol concentrations, psychiatric symptoms, and movement disorders in schizophrenic patients J Clin Psychiatry 50 4 1989 132 135
63. E.R. Azevedo, A.M. Schofield, S. Kelly, and J.D. Parker Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine J Am Coll Cardiol 37 2 2001 505 509
64. D. Hebert, and J.Y. Lam Nitroglycerin rebound associated with vascular, rather than platelet, hypersensitivity J Am Coll Cardiol 36 7 2000 2311 2316
65. N. Marsh, and A. Marsh A short history of nitroglycerine and nitric oxide in pharmacology and physiology Clin Exp Pharmacol Physiol 27 4 2000 313 319
66. S. Laowattana, B. Abou-Khalil, T. Fakhoury, and D. Ashmead Brief antiepileptic drug withdrawal prolongs interval to next seizure Neurology 53 8 1999 1736 1741
67. A. Takei, T. Fukazawa, T. Hamada, I. Yabe, and K. Tashiro 'Drug holiday' effects of tandospirone in a patient with Machado-Joseph disease Psychiatry Clin Neurosci 57 6 2003 607 608
68. M.L. Gaylor, and M. Duvic Generalized pustular psoriasis following withdrawal of efalizumab J Drugs Dermatol 3 1 2004 77 79
69. P. Kenemans, A.R. Genazzani, S. Palacios, and H.P. Schneider Pulsed estrogen exposure selectively modulates tissue response: a hypothesis Gynecol Endocrinol 18 3 2004 159 164
70. A.R. Genazzani, and F. Bernardi Estrogen effects on neuroendocrine function: the new challenge of pulsed therapy Climacteric 5 Suppl 2 2002 50 56
71. E. Ferrario, L. Ferrari, and P. Bidoli Treatment of cancer-related anemia with epoetin alfa: a review Cancer Treat Rev 30 6 2004 563 575
72. N. Oshitani, N. Kamata, and R. Ooiso Outpatient treatment of moderately severe active ulcerative colitis with pulsed steroid therapy and conventional steroid therapy Dig Dis Sci 48 5 2003 1002 1005
73. G. Haugeberg, B. Griffiths, K.B. Sokoll, and P. Emery Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study Ann Rheum Dis 63 8 2004 940 944
74. P.H. Dessein, B.I. Joffe, A.E. Stanwix, B.F. Christian, and M. Veller Glucocorticoids and insulin sensitivity in rheumatoid arthritis J Rheumatol 31 5 2004 867 874
75. R.P. Sundel, A.L. Baker, D.R. Fulton, and J.W. Newburger Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial J Pediatr 142 6 2003 611 616
76. M.H. Kropff, N. Lang, and G. Bisping Hyperfractionated cyclophosphamide in combination with pulsed dexamethasone and thalidomide (HyperCDT) in primary refractory or relapsed multiple myeloma Br J Haematol 122 4 2003 607 616
77. L.K. So, A.C. Lau, and L.Y. Yam Development of a standard treatment protocol for severe acute respiratory syndrome Lancet 361 9369 2003 1615 1617
78. A. Girdhar, J.K. Chakma, and B.K. Girdhar Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study Indian J Lepr 74 3 2002 233 236
79. I. Hedlund-Treutiger, J.I. Henter, and G. Elinder Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura J Pediatr Hematol Oncol 25 2 2003 139 144
80. T.A. Buchanan Pancreatic β-cell loss and preservation in type 2 diabetes Clin Ther 25 Suppl B 2003 B32 B46
81. K.S. Polonsky, J. Sturis, and E. Van Cauter Temporal profiles and clinical significance of pulsatile insulin secretion Horm Res 49 3-4 1998 178 184
82. T.H. Schurmeyer, H.M. Schulte, and P.C. Avgerinos Pharmacology of ovine and human CRH Horm Metab Res Suppl 16 1987 24 30
83. A.J. Martinez-Fuentes, L. Hu, L.Z. Krsmanovic, and K.J. Catt Gonadotropin-releasing hormone (GnRH) receptor expression and membrane signaling in early embryonic GnRH neurons: role in pulsatile neurosecretion Mol Endocrinol 18 7 2004 1808 1817
84. A.O. Mueck, H. Seeger, and D. Wallwiener 'Pulsed' estradiol action can stimulate breast cancer cell proliferation Clin Exp Obstet Gynecol 31 1 2004 23 24
85. R.F. Moellers, and L.A. Cogburn Pulsatile infusion of growth hormone-releasing factor depresses growth of young broiler chickens Comp Biochem Physiol Comp Physiol 107 4 1994 665 672
86. W.J. Kox, T. Volk, S.N. Kox, and H.D. Volk Immunomodulatory therapies in Sepsis Intens Care Med 26 Suppl. 1 2000 S124 S128
87. G. Monneret, A.L. Debard, and F. Venet Marked elevation of human circulating CD4 + CD25+ regulatory T cells in sepsis-induced immunoparalysis Crit Care Med 31 7 2003 2068 2071
88. G. Van den Berghe Endocrine evaluation of patients with critical illness Endocrinol Metab Clin North Am 32 2 2003 385 410
89. G. Van den Berghe Endocrinology in intensive care medicine: new insights and therapeutic consequences Verh K Acad Geneeskd Belg 64 3 2002 167 187
90. G.H. Van den Berghe, and F.E. De Zegher A senescent pattern of pituitary function during critical illness and dopamine treatment Verh K Acad Geneeskd Belg 58 4 1996 383 411
91. A.J. Yun, P.Y. Lee, and K.A. Bazar Temporal variation of autonomic balance and diseases during circadian, seasonal, reproductive, and lifespan cycles Med Hypotheses 63 1 2004 155 162
92. I.R. McDonald, A.K. Lee, K.A. Than, and R.W. Martin Failure of glucocorticoid feedback in males of a population of small marsupials Antechinus swainsonii during the period of mating J Endocrinol 108 1 1986 63 68
93. S. Schroeder, M. Wichers, and D. Klingmuller The hypothalamicpituitaryadrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone Crit Care Med 29 2 2001 310 316
94. J. Briegel, G. Schelling, M. Haller, W. Mraz, H. Forst, and K. Peter A comparison of the adrenocortical response during septic shock and after complete recovery Intens Care Med 22 9 1996 894 899
95. R.L. Rosenfield Current concepts of polycystic ovary syndrome Baillieres Clin Obstet Gynaecol 11 2 1997 307 333
96. S.D. Anderson, and J.D. Brannan Long-acting β-2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future Paediatr Drugs 6 3 2004 161 175
97. T. Partonen, O. Vakkuri, and C. Lamberg-Allardt Effects of exposure to morning bright light in the blind and sighted controls Clin Physiol 15 6 1995 637 646
98. K. Olofsson, C. Alling, D. Lundburg, and C. Malmros Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients Acta Anaesthesiol Scand 48 6 2004 679 684
99. T. Wakamura, and H. Tokura Influence of bright light during daytime on sleep parameters in hospitalized elderly patients J Physiol Anthropol Appl Human Sci 20 6 2001 345 351
100. Yun AJ, Lee PY, Bazar KA. Clinical benefits of hydration and volume expansion in a wide range of illnesses may be attributable to reduction of sympathovagal ratio. Med Hypotheses 2004, doi:10.1016/j.mehy.2004.07.014
101. D. Michelson, M. Fava, and J. Amsterdam Interruption of selective serotonin reuptake inhibitor treatment Br J Psychiatry 176 2000 363 368
102. J.F. Rosenbaum, M. Fava, S.L. Hoog, R.C. Ascroft, and W.B. Krebs Selective serotonin reuptake inhibitor discontinuation syndrome: A randomized clinical trial Biol Psychiatry 44 2 1998 77 87
103. M.M. Stahl, M. Lindquist, and M. Pettersson Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system Eur J Clin Pharmacol 53 3-4 1997 163 169
104. C.J. Whittington, T. Kendall, P. Fonagy, D. Cottrell, A. Cotgrove, and E. Boddington Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data Lancet 363 9418 2004 1341 1345
105. H. Kinugasa, and K. Hirayanagi Effects of skin surface cooling and heating on autonomic nervous activity and baroreflex sensitivity in humans Exp Physiol 84 2 1999 369 377
106. R.A. Desai, P.K. Maciejewski, D.J. Dausey, B.J. Caldarone, and M.N. Potenza Health correlates of recreational gambling in older adults Am J Psychiatry 161 9 2004 1672 1679